Yunlong Huang
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$4.7MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $4.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 5, 2024 | NIH | SBIR Phase II Preclinical evaluation of an otoprotectant TT002 | $326K | TING THERAPEUTICS LLC |
| Dec 4, 2024 | NIH | SBIR Phase II CDK2 inhibitors for protecting hearing loss | $175K | TING THERAPEUTICS LLC |
| Jul 17, 2024 | NIH | SBIR Phase II Preclinical evaluation of an otoprotectant TT002 | $1 | TING THERAPEUTICS LLC |
| Dec 1, 2023 | NIH | SBIR Phase II CDK2 inhibitors for protecting hearing loss | $177K | TING THERAPEUTICS LLC |
| Jul 20, 2023 | NIH | SBIR Phase II Preclinical evaluation of an otoprotectant TT002 | $566K | TING THERAPEUTICS LLC |
| Dec 10, 2022 | NIH | SBIR Phase II CDK2 inhibitors for protecting hearing loss | $541K | TING THERAPEUTICS LLC |
| Aug 1, 2022 | NIH | SBIR Phase II Preclinical evaluation of an otoprotectant TT002 | $1.2M | TING THERAPEUTICS LLC |
| Jul 26, 2022 | NIH | SBIR Phase II Preclinical evaluation of an otoprotectant TT002 | $621K | TING THERAPEUTICS LLC |
| Dec 1, 2021 | NIH | SBIR Phase II CDK2 inhibitors for protecting hearing loss | $1.1M | TING THERAPEUTICS LLC |
Peer ranks
Federal funding#299
Awards as PI#151
Patents#273
Companies
- TING THERAPEUTICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.